Report: Lilly drug decision unlikely before March
A pharmaceutical industry publication says the U.S. Food and Drug Administration is convening a February meeting to discuss prasugrel, a blood-thinner Eli Lilly and Co. hopes will be its next blockbuster. The move likely would delay a decision on the new drug until March, according to The Pink Sheet, a weekly publication that covers regulatory […]